|
|
home > news |
 |
 |
INDUSTRY NEWS AND PRESS RELEASES |
 |
|
Mogrify enters research collaboration with the MRC Laboratory of Molecular Biology
Exploratory research project aims to develop novel protein expression systems via cell reprogramming
Cambridge, UK, 11 January 2021: Mogrify Limited (Mogrify®), a UK company aiming to transform the development of ex vivo cell therapies and pioneer the field of in vivo reprogramming therapies, and the MRC Laboratory of Molecular Biology (LMB), a world-class research laboratory dedicated to understanding important biological processes at the molecular level, today announced an exploratory research collaboration. The project aims to develop novel protein expression systems by leveraging recent advances in direct cell reprogramming to help improve the production of proteins which are not produced sufficiently well in existing expression systems.
More>> |
|
|
Nova Biomedical FLEX2 Cell Culture Analyzer
Adds Sample Retain Capability
Waltham, MA–Nova Biomedical announces the addition of a Sample Retain Collector (SRC) for BioProfile FLEX2 cell culture analyzer. The FLEX2 automated cell culture analyzer measures up to 16 tests including pH, gases, metabolites, osmolality, cell density, and cell viability. A single FLEX2 analyzer with SRC and the previously introduced Online Sampler (OLS) module provides automated sampling and analysis of these key cell culture tests from as many as 10 bioreactors. This FLEX2 automation package saves hours of time versus manual sampling, analysis, sample storage, and after-hours cell culture monitoring.
More>> |
|
|
Etihad Cargo Reports 50% Y-O-Y Rise in Pharma Shipments
Carrier operates across more than 1,050 pharma trade lanes and counts 54 dedicated pharma stations in its global network. Etihad Cargo, the cargo and logistics arm of Abu Dhabi-based Etihad
Aviation Group, has reported a 50 per cent year-on-year rise in pharma
shipments under its specialised PharmaLife product.
More>> |
|
|
The biotech company baseclick GmbH launched a new and highly efficient method for SARS-CoV-2 mutation analysis
The rapid spread of the newly emerging SARS-CoV-2 virus variant B.1.1.7
in Great Britain and other countries shows changes in the genome of the
SARS-CoV-2 virus can lead to new biological properties. More>> |
|
|
Join Us In A New Free Webinar by Qloud
Our experience in qualifications has allowed us to
identify the necessary improvements for the resolution of data integrity
GAPs, and process optimization in regulated environments. More>> |
|
|
PHASTAR Announces Investment by Charterhouse Capital Partners
Funding will Support Expansion of Statistics and Data Science Services and Geographic Reach
PHASTAR, a specialist biometrics clinical research organization (CRO)
for clinical trials, announces an investment made by Charterhouse
Capital Partners LLP, a long-established European private equity firm,
which will support PHASTAR’s growth in biometrics and geographic
expansion. Charterhouse is making its investment in partnership with
PHASTAR’s Founder and CEO Kevin Kane, who remains a significant
shareholder in the business. Kevin and the existing management team will
continue to run, manage and operate the business on a day-to-day basis.
More>> |
|
|
Calyx Supports Breakthrough Therapy Approvals for Oncology Treatments
Calyx Medical Imaging and other eClinical services provide critical support for clinical development programs to deliver much-needed therapies to market
Calyx, the eClinical and regulatory solutions and services provider most
relied on for solving complex data challenges in clinical research,
today announced that its Medical Imaging and other eClinical solutions
supported half of the oncology treatments approved by the FDA as
Breakthrough Therapies in the past two years. More>> |
|
|
BIOGEN TO LAUNCH PIONEERING STUDY TO DEVELOP DIGITAL BIOMARKERS OF COGNITIVE HEALTH USING APPLE WATCH AND IPHONE
January 11, 2021 at 7:30 AM EST
The study aims to identify digital biomarkers to help monitor cognitive performance and health including potentially detecting mild cognitive impairment, an early indicator of certain forms of dementia such as Alzheimer’s disease
Cognitive health — the ability to think clearly, to learn and to remember — is an indicator of brain health and important to performing daily activities
More>> |
|
|
EQRx Scales Disruptive Model of Important New Medicines at Lower Prices with $500M Series B Financing
Funding accelerates development of late-stage cancer therapies, pipeline expansion and business growth
Syndicate includes all Series A investors, preeminent life science and generalist funds, and market-leading health systems and payers
More>> |
|
|
Servier and X-Chem Announce Drug Discovery Collaboration in Neurological Diseases
Funding accelerates development of late-stage cancer therapies, pipeline expansion and business growth
Syndicate includes all Series A investors, preeminent life science and generalist funds, and market-leading health systems and payers
More>> |
|
|
|
 |
|
|
 |
News and Press Releases |
 |
SICK’s Super Versatile, Ready-Made Quality Control System
SICK’s newly-developed MQCS (Modular Quality Control System) is an
“off the shelf”, multifunctional machine vision system, delivered as a
ready-to-use package of hardware and pre-written software. Suitable for
code reading, 2D or 3D inspection duties, the MQCS significantly reduces
cost and development time needed to set up automated quality inspection
and logistics applications in pharmaceutical production and packaging.
More info >> |
|
 |
White Papers |
 |
Bringing more control to temperature-sensitive logistics
UPS Supply Chain Solutions
By 2016, world sales of cold-chain drugs and biologics such as vaccines and blood plasma products will near $240 billion1. The increase has led to a surge in discussion about how to protect these products throughout the transportation logistics cycle. Industry experts are recommending that the term “cold chain” be eliminated from rules, guidance and best-practice documents. “Cold chain” now includes
a broader spectrum of temperature ranges, such as controlled room temperature (CRT). This white paper focuses on the initial steps required to establish a temperature-sensitive supply chain.
More info >> |
|
 |
Industry Events |
 |
12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
8-11 February 2021, Vienna, Austria
In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >> |
|
|